AL
TME Pharma N.V.
ALTME.PA · PAR
0.11 € +0.00% (+0.00 €)
1M -30.77%
Market Cap 10.4M €
P/E Ratio -
Div. Yield -
ROE 1,273.26%
Piotroski F-Score Weak
1/9Valuation
-
N/A P/B N/A
EV/FFO N/A
P/E N/A
Growth
-
N/A Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
0 /100
Poor Asset turnover 0.00x
ROA 153.58%
ROIC 270.01%
Debt
5 /100
High Int. coverage -2.67x
Current ratio 0.57x
Net debt/EBITDA N/A
Stability
80 /100
Stable EPS volatility 3.34%
Profitable years 0
Beta 0.61x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ALTME.PA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Diede van den Ouden
Employees
12
Headquarters
Berlin